Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Hormonal Control of Alveolar Development and Its Implications for Breast Carcinogenesis

    During puberty and pregnancy, the breast undergoes major restructuring in order to produce a structure that can secrete and eject copious amounts of milk. By analogy to other branched organs such as the lung o...

    Cathrin Brisken in Journal of Mammary Gland Biology and Neoplasia (2002)

  2. Article

    Prolactin signaling and Stat5: going their own separate ways?

    Miyoshi et al. compared the role of the prolactin receptor (PrlR) and its downstream mediator, the signal transducer and activator of transcription 5 (Stat5), in mammary epithelial cells in vivo by studying PrlR-...

    Cathrin Brisken, Ayyakkannu Ayyanan, Wolfgang Doppler in Breast Cancer Research (2002)

  3. No Access

    Article

    Using Gene Expression Arrays to Elucidate Transcriptional Profiles Underlying Prolactin Function

    Prolactin is an ancient hormone, with different functions in many species. The binding of prolactin to its receptor, a member of the cytokine receptor superfamily, results in the activation of different intrac...

    Sandra Gass, Jessica Harris, Chris Ormandy in Journal of Mammary Gland Biology and Neopl… (2003)

  4. No Access

    Article

    Identification of molecular apocrine breast tumours by microarray analysis

    Previous microarray studies on breast cancer identified multiple tumour classes, of which the most prominent, named luminal and basal, differ in expression of the oestrogen receptor α gene (ER). We report here th...

    Pierre Farmer, Herve Bonnefoi, Veronique Becette, Michele Tubiana-Hulin in Oncogene (2005)

  5. No Access

    Article

    Alveolar and Lactogenic Differentiation

    The mouse mammary gland is a complex tissue that proliferates and differentiates under the control of systemic hormones during puberty, pregnancy and lactation. Once a highly branched milk duct system has been...

    Cathrin Brisken, Renuga Devi Rajaram in Journal of Mammary Gland Biology and Neoplasia (2006)

  6. No Access

    Article

    Stem Cells and the Stem Cell Niche in the Breast: An Integrated Hormonal and Developmental Perspective

    The mammary gland is a unique organ in that it undergoes most of its development after birth under the control of systemic hormones. Whereas in most other organs stem cells divide in response to local stimuli,...

    Cathrin Brisken, Stephan Duss in Stem Cell Reviews (2007)

  7. Article

    Open Access

    An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells

    About 70% of breast cancers express oestrogen receptor α (ESR1/ERα) and are oestrogen-dependent for growth. In contrast with the highly proliferative nature of ERα-positive tumour cells, ERα-positive cells in ...

    Stephan Duss, Sylvie André, Anne-Laure Nicoulaz, Maryse Fiche in Breast Cancer Research (2007)

  8. Article

    From normal cell types to malignant phenotypes

    The phenotypic diversity of breast cancer has been proposed to result from different target cell types undergoing oncogenic transformation and giving rise to cancer stem cells. Global gene expression profiling...

    Özden Yalcin-Ozuysal, Cathrin Brisken in Breast Cancer Research (2009)

  9. No Access

    Article

    Stem cells in chemical carcinogenesis

    Cornelia Dietrich, Carsten Weiss, Ernesto Bockamp in Archives of Toxicology (2010)

  10. Article

    High hopes for RANKL: will the mouse model live up to its promise?

    The steroid hormones, estrogens and progesterone are key drivers of postnatal breast development and are linked to breast carcinogenesis. Experiments in the mouse mammary gland have revealed that they rely on ...

    Tamara Tanos, Cathrin Brisken in Breast Cancer Research (2011)

  11. Article

    ER and PR signaling nodes during mammary gland development

    The ovarian hormones estrogen and progesterone orchestrate postnatal mammary gland development and are implicated in breast cancer. Most of our understanding of the molecular mechanisms of estrogen receptor (E...

    Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria in Breast Cancer Research (2012)

  12. No Access

    Article

    Progesterone signalling in breast cancer: a neglected hormone coming into the limelight

  13. Mutations are not always sufficient to drive breast carcinogenesis but additional factors determine whether genetically altered cells progress to the state dur...

  14. Cathrin Brisken in Nature Reviews Cancer (2013)

  15. No Access

    Article

    Does Cancer Start in the Womb? Altered Mammary Gland Development and Predisposition to Breast Cancer due to in Utero Exposure to Endocrine Disruptors

    We are now witnessing a resurgence of theories of development and carcinogenesis in which the environment is again being accepted as a major player in phenotype determination. Perturbations in the fetal enviro...

    Ana M. Soto, Cathrin Brisken in Journal of Mammary Gland Biology and Neopl… (2013)

  16. Article

    Reply to Is progesterone a neutral or protective factor for breast cancer?

    Cathrin Brisken in Nature Reviews Cancer (2014)

  17. No Access

    Article

    Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

    Stromal fibroblast senescence has been linked to ageing-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAFs) are frequently increased. Loss or downmodulation of th...

    Maria-Giuseppina Procopio, Csaba Laszlo, Dania Al Labban in Nature Cell Biology (2015)

  18. Article

    Correction: Corrigendum: Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

    Nat. Cell Biol. 17, 1193–1204 (2015); published online 24 August 2015; corrected after print 28 August 2015 An error in the print version of this Article meant that Witold W. Kilarski's name was incorrect. Thi...

    Maria-Giuseppina Procopio, Csaba Laszlo, Dania Al Labban in Nature Cell Biology (2015)

  19. No Access

    Article

    Patient-derived xenograft (PDX) models in basic and translational breast cancer research

    Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical re...

    Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez in Cancer and Metastasis Reviews (2016)

  20. No Access

    Protocol

    Analysis of Mammary Gland Phenotypes by Transplantation of the Genetically Marked Mammary Epithelium

    The mammary gland is the only organ to undergo most of its development after birth and therefore particularly attractive for studying developmental processes. In the mouse, powerful tissue recombination techni...

    Duje Buric, Cathrin Brisken in Mammary Gland Development (2017)

  21. No Access

    Chapter

    Breast Cancer Microenvironment and the Metastatic Process

    Metastases are the main cause of breast cancer-related death: hence, the clinical need to prevent and to stop metastasis is of outmost importance. Evidence has accumulated that the propensity of breast cancer ...

    George Sflomos, Cathrin Brisken in Breast Cancer (2017)

  22. Article

    Open Access

    Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium

    Oestrogen receptor α (ERα) is a transcription factor with ligand-independent and ligand-dependent activation functions (AF)-1 and -2. Oestrogens control postnatal mammary gland development acting on a subset o...

    Stéphanie Cagnet, Dalya Ataca, George Sflomos, Patrick Aouad in Nature Communications (2018)

previous disabled Page of 2